3m Transcript 2006 1st


Published on

Published in: Economy & Finance
  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

3m Transcript 2006 1st

  1. 1. Q1 2006 Earnings Conference Call Transcript Mark Colin- Director, Investor Relations Good morning, I'm Mark Colin, Director of Investor Relations for 3M, and welcome to our first quarter 2006 business review. Before we begin, I have a few brief announcements. As in prior quarters, today’s discussion will follow a series of PowerPoint slides, which are currently available on our investor relations website. Looking ahead, our 2006 second-quarter earnings conference call will take place Tuesday, July 25th. Please mark your calendars accordingly. During today’s conference call, we will make certain predictive statements that reflect our current views and estimates about our future performance and financial results. These statements are based on certain assumptions and expectations of future events that are subject to risks and uncertainties. Item 1A of our most recent form 10-K lists some of the most important risk factors that could cause actual results to differ from our predictions. Also, as we discussed in our 2005 10K, effective January 1st, we combined our Industrial and Transportation business into one business. The new business leverages common markets and customers, as well as common channels, technologies, manufacturing base and selling processes. In addition, during the first-quarter the Personal Care and Related Products Division within the Health Care segment transferred to the combined Industrial and Transportation segment. And finally, beginning in 2006, we adopted the expensing of stock options and have elected to restate prior periods. Our comparisons and historical information included in our press release and also provided via Form 8K published earlier this week have been adjusted for these realignments. George Buckley, 3M’s chief executive officer, and Pat Campbell, our CFO will handle the formal comments of today’s call and then we will open it up for Q&A. And now I'd like to turn the program over to Pat. Pat Campbell- Chief Financial Officer Thanks Mark, and good morning everyone. Let’s begin with some key highlights from the first-quarter. Please turn to slide number two. This was an outstanding quarter for 3M. Sales reached an all time high of $5.6 billion, up 8.3 percent over the first quarter of 2005. In local-currency terms we generated sales growth of 10.4 percent, including 2.3 percent from acquisitions, primarily CUNO. Our organic local-currency growth of 8.1% in the first quarter was the highest since Q2 2000. The real highlight this quarter, from both a business segment and geographic perspective, was the breadth of this outstanding performance. All six of our businesses delivered
  2. 2. strong local currency sales growth, ranging from Health Care, which was up 4.9 percent, to Safety and Security which experienced local currency growth of over 15 percent. On a geographic basis, organic local-currency sales growth was 12.0% in Asia Pacific, 7.9% in Europe and 7.4% in the U.S. The timing of the Easter holiday had a favorable impact in the quarter of approximately 1% on our overall growth rate. And this is not just a sales growth story. We had an outstanding quarter on the income side as well. Operating income in the first quarter was $1.4 billion, up 18.8%. Four of our six businesses posted double-digit operating income increases, and this was 3M’s 17th consecutive quarter of year-over-year earnings and margin expansion. Reported EPS came in at $1.17, up over 20%. Included in this result is $0.02 of option expense for first-quarter 2006 compared to $0.06 for the first-quarter of 2005. The year- on-year decrease in option expense this quarter is a result of a change in our options vesting period from one year to three years starting with the May 2005 option grant. Another highlight this quarter was our board’s action in February authorizing a dividend increase of 9.5% for 2006. This marks the 48th consecutive year of annual dividend increases for the company. As we commented in our press release on April 4th, we are pursuing strategic alternatives for our branded pharmaceuticals business. This business has been very successful, however, its investment and risk profiles are different than most other 3M businesses and, frankly, we feel that the best way to maximize value is to combine it with a dedicated pharmaceutical company. We have engaged Goldman Sachs to lead the process for us. As you can tell from these results we are off to a great start in 2006, and our performance this quarter gives us tremendous confidence in the ability of our teams around the world to drive accelerated growth, which continue to achieve superior financial results. On slide three we recap our first-quarter sales performance on a geographic basis. As I previously mentioned, worldwide sales in dollar terms increased 8.3% versus last year’s first-quarter. Volumes increased 10.4%, with core volumes up 8.1% and acquisitions adding 2.3% to growth. Selling prices in the quarter were flat while year-on- year currency translation reduced reported sales by 2.1 percentage points. In the United States, sales improved 10.8% vs. last year’s first-quarter. Organic local currency growth in the quarter was 7.4% with volume up 5.3% and selling prices adding 2.1%. This is the highest organic local-currency sales growth in the U.S. since the first- quarter of 2000. U.S. organic growth was strong across the portfolio as five of our six businesses delivered double-digit organic local-currency growth. Acquisitions added 3.4% to growth in the U.S. in the first quarter.
  3. 3. Sales in our international operations were up 6.8% in U.S.-dollar terms. Local-currency sales were up 10.3%, with organic volumes increasing 9.8% and selling prices decreasing 120 basis points. Acquisitions added 1.7% of additional growth. International selling prices continued to be negatively impacted by our businesses that serve the consumer electronics industry. However, our total revenue growth in our consumer and electronics related businesses remained strong. Currency translation reduced first-quarter sales by 3.5%. Organic local-currency growth was 12.0% in Asia Pacific, with Japan up almost 3.0%, and the rest of the region up 18%. Acquisitions added 1.8 points of additional growth in the quarter. All six of our businesses posted positive local-currency growth in Asia Pacific during the quarter. Europe delivered 7.9% local-currency growth, its best result since Q2 of 2000. Acquisitions added an additional 1.6% to growth in Europe in the first quarter. Since Easter is in the second-quarter this year compared with the first-quarter last year, first- quarter local currency growth in Europe benefited from additional billing days. We estimate the Easter benefit to Europe’s first-quarter local-currency growth to be about 4 percentage points. And finally, we posted 1.2% organic local-currency growth in the combined Latin America and Canada. Excluding the impact of the decline in our CRT rear projection lens business in Mexico and the move of a flex circuit customer from Puerto Rico to Singapore, the Latin America Canada region’s organic local-currency increased 5.2%, led by Consumer and Office, Health Care and Industrial and Transportation businesses. The CUNO acquisition added an additional 1.7% to growth in the quarter. On slide number four, we compare our first-quarter P&L versus last year’s comparable quarter. Again, note that we elected to restate prior periods for the expensing of stock options. Therefore all numbers shown from this point on will reflect this restatement. As I previously mentioned sales were up a strong 8.3% year-over-year. Gross margins were 51.4%, up 70 basis points from last year’s first quarter. This improvement was the result of continued focus on driving productivity in our factories, along with volume and mix benefits, which more than stayed ahead of inflationary pressures. SG&A expense was 21.1% of sales, down 1.1 percentage points despite our investing rather aggressively in areas where there is clear line of sight to revenue growth – namely advertising, promotional programs and feet on the street. We kept a tight lid on administrative expenses in the quarter, and lower management stock option expenses accounted for 60 basis points of the year-on-year improvement.
  4. 4. Excluding options expense in both years for R and D and related expenditures, they increased almost 4.0% year-over-year, as we continue to aggressively invest in future growth for the company. Operating margins continue to expand, finishing at 24.5%. Lower cash balances and higher interest rates drove up first-quarter net interest expense, which was $14 million versus $4 million last year. 3M's tax rate for the first quarter was 32.7%, up just slightly from recent quarters. Aside from the impact of stock options, the tax rate reflects a 30 basis point increase due to the expiration of the R&D and Orphan Drug Tax Credits on December 31 of last year. In the event the IRS or Internal Revenue Code is amended to reinstate these credits, the corresponding positive impact would be reflected in our tax rate in future quarters. Quarterly net income increased 16.6% year-on-year and earnings-per-share increased 20.6%. These results include a $17 million after-tax impact, or $0.02 per share, due to expensing of stock options in this year’s first-quarter versus $38 million after-tax, or $0.06 per share, in last year’s first-quarter. We have provided future stock option expense detail in the attachment to this morning’s press release as well as the 8K published earlier this week. The P&L on a sequential basis is found on slide number 5 and reflect solid improvements in all categories. Sales were up 5.1% versus the fourth quarter of last year, as five of our six businesses drove positive sequential growth. We leveraged this increase into a 15.0% operating income improvement. Operating margins improved by 210 basis points sequentially, driven by a combination of accelerating sales and ongoing productivity. On a sequential basis, net income and earnings-per-share increased 15.2% and 15.8%, respectively. These results include a $0.02 impact from the expensing of options in each quarter. Now, if you would turn to slide number six, I will review a few balance sheet and cash flow metrics. Our net working capital turns were down reflecting higher volumes and our strategy to improve customer service to drive further growth. Many of our supply chains are currently constrained and we are building inventory in some cases to meet anticipated higher demand. We have approved additional capital expenditures to increase capacity but it will take awhile before this capacity is in place. Capital expenditures were $190 million in the first-quarter. We expect our capital expenditures to accelerate throughout 2006 to approximately $1.1 billion for the year,
  5. 5. which would be a 16% increase year-over-year. This acceleration is demand driven, as our capital needs are to a large extent supporting growing businesses such as optical films, medical products, commercial graphics, Scotch blue masking tape, roofing granules, respiratory protection products and Filtrete filters to name a few. And the rapid growth in developing economies, one of 3M’s most significant opportunities for sustainable top-line growth, is also fueling the need for additional capital over the next several quarters. First-quarter free cash flow of $435 million was lower than last year for two primary reasons. First, as I just mentioned, we invested in working capital in Q1 in anticipation of continued firm sales volumes. Second, we made higher estimated tax payments to the IRS in the first quarter vs. the same quarter last year, primarily related to our record level of dividend repatriation from foreign subsidiaries back into the U.S. during the last half of 2005, including the portion related to the American Jobs Creation Act. We paid $347 million in dividends to our shareholders in the first-quarter. Our stock repurchase activity during the quarter was low as we were out of the market for awhile as we were formulating our decision on Pharmaceuticals business. As a result, our share repurchases were $251 million with a net repurchase of $151 million during the quarter. Weighted average diluted shares outstanding were 768.6 million, down about 2.3% from last year. Our debt to capital ratio was 19.3% at the end of the quarter. Please now turn to slide number 7, where we will examine our results by business segment. Please note that we have added an additional column to our business results chart this quarter to reflect the year-on-year percentage operating income impact from the expensing of stock options for each segment to help in better understanding our results. For example, our Industrial and Transportation business operating income growth was 5.5% higher due to the impact of lower stock option expense in Q1 2006 vs. Q1 2005. As I mentioned we moved from a one-year to a three-year vesting period which resulted in a lower option expense in the first quarter of 2006 compared to the first-quarter of 2005. And now I would like to turn the program over to George to discuss our performance by business. George…… George Buckley- Chairman, President and Chief Executive Officer Thank you very much Pat and good morning everyone. Our Industrial and Transportation business delivered a strong quarter with local-currency sales growth of 14.0% including 7.5% from the CUNO acquisition. Operating income in the first-quarter was $381 million, or up almost 24.0%. Growth in this segment was led by CUNO, complemented by strong performance in our industrial adhesives and tapes business, and our automotive aftermarket division where innovative products such as our new paint preparation system are driving growth by improving the productivity of our customers. The CUNO acquisition continues to meet our expectations with local-currency growth of over 14% versus the same quarter last
  6. 6. year when CUNO was an independent company. We remain excited about CUNO’s tremendous growth prospects, particularly in emerging markets. As we have mentioned in some past quarters, our Personal Care diaper tape business sales have been declining as we have lost volume due to our pricing strategy aimed at improving the profitability of the business. I think it’s also fair to say that we didn’t event as much as we should’ve in this business. We continue to work hard to recover volume over time by bringing new products to our customers that we believe will make us more competitive but this will take a little while. The sales decline in our personal care business negatively impacted Industrial and Transportation’s segment growth by 1.4% in the quarter. The Health Care business got off to a good start to the year with sales of $966 million in the quarter, up 4.9% in local-currency terms. Operating income increased almost 10% to $298 million year-on-year. Excluding our pharmaceuticals business, which is approximately 20% of Health Care, our first-quarter local-currency sales were up 6.8% with operating income remaining at about 10%. Worldwide local-currency sales in our medical and dental businesses grew at double-digit rates in the quarter. Growth in Health Care was driven by the strength of our infection prevention and acute wound care products, our leading technology positions in new products such as Littman electronic stethoscopes, and our innovative dental products such as our Lava crowns and bridges digital dentistry system. Geographically, local-currency growth rate in our Health Care business was led by the Asia Pacific region where we are focused on driving infection prevention and dental platforms into the rapidly growing health care markets in the developing countries. Also, during the quarter we announced that we have successfully closed the acquisition of OMNII Oral Pharmaceuticals. Adding OMNII's preventive expertise, products, and capability to educate, will enable us to deliver even more value to dental practices while participating in a rapidly growing segment. We are committed to continuing to strengthen and expand our position in the dental industry. As we commented in our press release on April 14, April 4th, forgive me, relative to our successful branded pharmaceuticals business, in today's very competitive pharmaceutical marketplace, continued success requires broad pipelines of new drugs, significant investments, and a longer term risk-reward business model than applies to most other 3M businesses. We believe that the best way for this business to grow is for it to be free to pursue separate strategies under the direction of a dedicated pharmaceutical industry company with a business model better suited to maximizing its potential. We feel the business is a very valuable asset and there are more opportunities for technology and market synergies with a company other than 3M. So, as Pat mentioned earlier, we have engaged Goldman Sachs to lead the process for us. We will provide further updates to you as warranted as we work our way through this process. Moving on, Display and Graphics had another outstanding quarter with local-currency sales growth of 9.5%, to $915 million. First-quarter operating income was $296 million,
  7. 7. up almost 4%. As in past quarters, sales and operating income in Display and Graphics was dampened by the continuing decline of our CRT rear projection lens business. Excluding the negative impact of that business sales and operating income would have been up a very nice 13.0% and 12.1%, respectively. Matching last quarter’s record, the ongoing strength of the consumer electronics industry drove demand for our proprietary optical films and components business. We experienced all time record first-quarter revenues in the film business as we posted double-digit local-currency growth in the quarter. This business is driven in part by the strength of a rich intellectual properties portfolio that we are continually expanding upon. Focused capital investments are also being deployed to accelerate commercialization of the next generation reflective polarizer films to meet the long-term cost and performance requirements of the growing LCD-TV market. Pricing in our LCD films business remained at a similar rate to last quarter as a result of normal industry pricing pressure. Commercial Graphics delivered strong local-currency growth in the first-quarter with strong end market penetration and differentiated products that offer superior value to customers. And finally, Traffic Safety Systems continued the momentum from the second half of last year with a continued focus on innovative new products such as diamond grade reflective traffic signs. Consumer and Office’s organic local-currency sales growth of 8.1% was broad based across the portfolio. The acquisition of InterChemall, a Polish manufacturer of home care products, added an additional 30 basis points of growth in the quarter. Operating income in Consumer and Office was $136 million, up over 19%. In Consumer and Office we continue to penetrate our large key accounts with new products with unique functionality along with customer inspired design. Our Consumer and Office team has developed a strong track record of introducing innovative new products such as the recent launch of Post It Picture Paper, which is being supported by a national advertising campaign. Our line of Nexcare consumer health care products was another notable growth driver in the quarter. Our Visual Systems business, primarily analog overhead and electronic projectors and film, continued to experience a decline reducing overall Consumer and Office Sales by 1.7% in the quarter. Safety, Security and Protection Services business had an outstanding first-quarter. Local- currency sales increased 15.6%, to $631 million. We continue to invest in additional capacity here, particularly, for our respiratory and roofing granules businesses, to support higher end market growth. Profits globally improved 30.3% year-on-year to $164 million.
  8. 8. Geographically, local-currency growth was positive across all regions led by Europe, Asia Pacific and the U.S. We experienced broad based growth in safety solutions, including respiratory, hearing, eye and face protection, along with robust demand for our cleaning and protection products for commercial and residential buildings. For the second consecutive quarter our Electro and Communications business delivered double-digit organic local-currency growth. Organic local-currency growth in the quarter was 10% with an additional 70 basis points coming from our acquisition of flexible circuit technology for ultrasound machines from Siemens. Electro and Communications leveraged this growth and a continued focus on productivity into a 33.2% improvement in operating income to $127 million. This result was driven by outstanding growth in consumer electronics, where our products such as Form-In-Place Gaskets for sealing hard disk drive covers, flexible circuits, films, adhesives and tapes for bonding, protection, and vibration dampening solve the unique needs of our diverse and global electronics manufacturing customers. We also had excellent local-currency growth in our Electrical Markets business, where we offer a wide array of insulating, testing, and sensing solutions to the electrical utility and infrastructure industries. If you’d now please turn to slide eight, where I will discuss our guidance for the second- quarter and the remainder of 2006. Looking ahead to the second-quarter, we expect business conditions to be very similar to what we saw this past quarter. We expect second-quarter organic local-currency growth of 5.0 to 8.0 percent with acquisitions adding an approximately an additional 2.5 points of growth. Second-quarter growth will be negatively impacted by approximately one percent due to Easter now being in Q2. Second-quarter earnings-per-share are expected to be in the range of $1.14 to $1.17, including $0.08 per share impact from stock options expensing. 2005 second-quarter earnings-per-share, restated to reflect stock options expensing of $0.04 per share, were $1.06. As Pat discussed last quarter, we will have some lumpiness quarter-to-quarter in our options expense, particularly in the second-quarter due to a requirement under FAS123R to immediately expense stock option grants for those employees who are considered retirement eligible. A 3M employee is considered to be retirement eligible upon reaching age 55 with 5 years of service. Approximately 25-30% of the annual grant award is to these employees. Since we grant our employee stock options in the second- quarter, the immediate expensing stock option grants to retirement eligible employees results in higher stock option expense in the second-quarter. Accounting rules do not allow restatement for the retirement eligible impact. Building on our strong first-quarter performance, we now expect full year 2006 earnings- per-share to be within the range of $4.55 to $4.65, including a $0.16 impact from option expensing in 2006 and $0.14 in 2005. Organic local-currency growth is expected to by
  9. 9. 5.5 to 8.0 percent with closed acquisitions adding approximately an additional 1.5 points of growth. During the second-quarter, we anticipate that we will likely resolve several outstanding items. First of all we expect the favorable completion of a number of worldwide tax audits. Next, we are scheduled for a late spring trial of a certified class action brought by direct purchasers of 3M transparent tape and invisible tape that is pending in a federal court in Pennsylvania that was disclosed in our 2005 10K. And finally, we may incur restructuring charges or other expenses in connection with our pharmaceuticals business. In that these items are not currently estimable, they are not in our second-quarter or full year guidance. So, before we begin the question and answer, let me summarize our results. This was another outstanding quarter for 3M, characterized by broad-based growth from our entire portfolio and continued strong leverage to the bottom line. Quarterly sales reached an all- time high with local-currency growth of over 10 percent, and we delivered a double-digit net income increase while also accelerating our investments in the future. We are off to a very strong start in 2006, which gives me great confidence in the ability of our teams around the world to drive accelerated growth and achieve superior financial results. In fact, this confidence in our team is what led us to raise both our full-year growth and our earnings guidance. This concludes the formal part of today’s call so let’s now begin the Q&A.